Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rodgers

Showing results (271-280 of 356) with videos related to

Pageof 36
Sort By:
JAMA|September 23, 2015
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical TrialClara K Chow, Julie Redfern, Graham S Hillis, et al.
JAMA Cardiology|July 28, 2020
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH TrialNelson Wang, Abdul Salam, Ruth Webster, et al.
BMJ Open|February 17, 2021
Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of HypertensionSonali Rukshana Gnanenthiran, Claudio Borghi, Dylan Burger, et al.
BMJ Open|August 24, 2024
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adultsCheryl Carcel, Lauren Clancy, Katie Harris, et al.
Heart (British Cardiac Society)|September 16, 2025
Predicting cardiovascular events from routine mammograms using machine learningJennifer Yvonne Barraclough, Ziba Gandomkar, Robert A Fletcher, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
The Lancet. HIV|March 30, 2018
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
Journal of Hypertension|August 19, 2022
Impact of various night-time period definitions on nocturnal ambulatory blood pressureJanis M Nolde, Graham S Hillis, Emily Atkins, et al.
Journal of Hypertension|June 19, 2025
Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statementJames E Sharman, Aletta E Schutte, Mark R Nelson, et al.
Circulation|July 24, 2023
Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET StudyJanis M Nolde, Emily Atkins, Simone Marschner, et al.
Pageof 36

Showing results (271-280 of 356) with videos related to

Sort By:
Pageof 36
JAMA|September 23, 2015
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical TrialClara K Chow, Julie Redfern, Graham S Hillis, et al.
JAMA Cardiology|July 28, 2020
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH TrialNelson Wang, Abdul Salam, Ruth Webster, et al.
BMJ Open|February 17, 2021
Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of HypertensionSonali Rukshana Gnanenthiran, Claudio Borghi, Dylan Burger, et al.
BMJ Open|August 24, 2024
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adultsCheryl Carcel, Lauren Clancy, Katie Harris, et al.
Heart (British Cardiac Society)|September 16, 2025
Predicting cardiovascular events from routine mammograms using machine learningJennifer Yvonne Barraclough, Ziba Gandomkar, Robert A Fletcher, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
The Lancet. HIV|March 30, 2018
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
Journal of Hypertension|August 19, 2022
Impact of various night-time period definitions on nocturnal ambulatory blood pressureJanis M Nolde, Graham S Hillis, Emily Atkins, et al.
Journal of Hypertension|June 19, 2025
Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statementJames E Sharman, Aletta E Schutte, Mark R Nelson, et al.
Circulation|July 24, 2023
Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET StudyJanis M Nolde, Emily Atkins, Simone Marschner, et al.
Pageof 36